Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Impact of tapering targeted therapies (bDMARDs or JAKis) on the

The state of the art—psoriatic arthritis outcome assessment in

Full article: POSTER PRESENTATIONS

PDF) Impact of Secukinumab on Patient-Reported Outcomes in the

Efficacy of a tight-control and treat-to-target strategy in axial

Validation of the Ankylosing Spondylitis Disease Activity Score

Upadacitinib efficacious in patients with ankylosing spondylitis

PDF) Work Disability in Axial Spondyloarthritis

Disease Activity-Guided Stepwise Tapering but Not Discontinuation

PDF) Baseline patient characteristics associated with response to

Maintained activity in ankylosing spondylitis patients treated